IH
UTHR icon

IFC Holdings’s United Therapeutics UTHR Stock Holding History

IFC Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,498
Closed -$481K – 396
2015
Q3 		$481K Sell
3,498
-34
-1% -$5.45K 0.07% 188
2015
Q2 		$620K Buy
3,532
+39
+1% +$7.02K 0.09% 178
2015
Q1 		$603K Buy
3,493
+806
+30% +$123K 0.09% 181
2014
Q4 		$354K Buy
2,687
+197
+8% +$25.4K 0.06% 246
2014
Q3 		$320K Buy
2,490
+105
+4% +$10.8K 0.06% 247
2014
Q2 		$214K Hold
2,385
– – 0.04% 315
2014
Q1 		$216K Sell
2,385
-391
-14% -$40K 0.04% 288
2013
Q4 		$315K Sell
2,776
-13,413
-83% -$1.21M 0.07% 243
2013
Q3 		$1.28M Buy
16,189
+406
+3% +$29.7K 0.28% 95
2013
Q2 		$1.03M Buy
+15,783
New +$1.02M 0.25% 97

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

IFC Holdings's UTHR Position: Q4 2015 in Review

IFC Holdings sold out of United Therapeutics (UTHR) in Q4 2015, closing a stake of 3,498 shares — an estimated $481K sold.

IFC Holdings first reported a position in UTHR in Q2 2013 and held it in 10 quarters. The position peaked at $1.28M in Q3 2013. 386 funds tracked by Wall St. Rank hold UTHR as of Q4 2015.

  • IFC Holdings reported no remaining United Therapeutics position as of Q4 2015 after selling out during the quarter.
  • IFC Holdings sold 3,498 United Therapeutics shares in Q4 2015, an estimated $481K.
  • IFC Holdings first reported a position in United Therapeutics in Q2 2013 and held it in 10 quarters.
  • IFC Holdings's United Therapeutics position peaked at $1.28M in Q3 2013.
  • 386 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2015.

Based on IFC Holdings's 13F filing for Q4 2015, filed 3 Feb 2016.